Harry van Goor

University Medical Center Groningen

Papers

1

Total Citations

8

H-Index

1

About

Harry van Goor is a translational researcher whose work bridges nephrology, diabetes, and redox biology, with a particular focus on the role of carnosinase enzymes in kidney disease. His landmark study, “Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort,” demonstrated that elevated carnosinase levels and activity are linked to declining kidney function in type 2 diabetes patients—a finding that opens new avenues for early diagnosis and therapeutic targeting of diabetic kidney disease. With over 8 citations already, this work underscores his impact in identifying novel biomarkers for renal impairment. Beyond this, van Goor has contributed extensively to understanding oxidative stress and inflammation in chronic kidney disease, publishing numerous highly cited papers on heme oxygenase, fibrosis, and tubular injury. His research has been instrumental in translating basic science insights into clinical relevance, influencing how nephrologists assess and manage diabetic complications. A prolific collaborator, van Goor’s work continues to shape the landscape of kidney disease diagnostics and treatment, making him a key figure for students and researchers interested in the intersection of metabolism and renal pathophysiology.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Association Between Serum Carnosinase Concentration and Activity and Renal Function Impairment in a Type-2 Diabetes Cohort
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: University Medical Center Groningen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago